Featured Research

from universities, journals, and other organizations

Gene therapy as a new option for bone defects

Date:
December 7, 2012
Source:
Medical University of Vienna
Summary:
Gene therapy involving modified stem cells obtained from fatty tissue and bone marrow could represent a new option for the treatment of severe orthopaedic injuries to the extremities. The treatment could in future prevent threatened amputations or massive shortenings of bones.

Martina Hauser-Schinhan.
Credit: Image courtesy of Medical University of Vienna

Gene therapy involving modified stem cells obtained from fatty tissue and bone marrow could represent a new option for the treatment of severe orthopaedic injuries to the extremities. This treatment has been developed by Martina Hauser-Schinhan from the University Department of Orthopaedics at the MedUni Vienna during a research fellowship at the Center for Advanced Orthopedic Studies at the Harvard Medical School. The treatment could in future prevent threatened amputations or massive shortenings of bones.

The new method involves altering the body's own stem cells, obtained from fat or bone marrow, with BMP-2 genes which are known to promote bone healing. The autologous stem cells that are genetically modified with ad.BMP-2 are embedded in a fibrin gel which is applied between the two broken parts of the bone. The stem cells continuously produce BMP-2, like a power plant. The stem cells and the BMP-2 cause the bones to heal. "Until now, in cases of severe injury that we would be able to treat with this method, amputations or bone shortening surgery were often necessary," says Hauser-Schinhan.

The new treatment option has been used in in vivo trials and clinical studies are set to follow. The results so far invite the conclusion that healing occurs within a few weeks. Says Hauser-Schinhan: "Even with normal bone fractures, it takes six weeks." Its use even after the removal of bony tumours, which involves taking away large portions of bone, appears to be possible according to the MedUni researcher.

Hauser-Schinhan carried out research at Harvard between April 2011 and April 2012. The local Center for Orthopedics, led by Christopher Evans, who has collaborated closely for many years with the Head of Department in Vienna Reinhard Windhager, is renowned for its work on gene therapy and its use in the healing of bone defects.


Story Source:

The above story is based on materials provided by Medical University of Vienna. Note: Materials may be edited for content and length.


Cite This Page:

Medical University of Vienna. "Gene therapy as a new option for bone defects." ScienceDaily. ScienceDaily, 7 December 2012. <www.sciencedaily.com/releases/2012/12/121207090428.htm>.
Medical University of Vienna. (2012, December 7). Gene therapy as a new option for bone defects. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2012/12/121207090428.htm
Medical University of Vienna. "Gene therapy as a new option for bone defects." ScienceDaily. www.sciencedaily.com/releases/2012/12/121207090428.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins